Framework agreement for pharmaceutical products in 13 lots (1/DLII6/VM131)
- Place
- Germany (delivery locations as set out in the performance specification, Annex 1)
- Deadline for receipt of tenders
- 07:00 AM · UTC
- Contract value
- Not stated in the notice
- Lots
- 13 lots
- Contract period
- Estimated 1 February 2027 to 31 January 2029 (the conclusion date is an estimate)
- Published
- October 27, 2026
- TED notice 747795-2026 (HTML view, change notice) and canonical snapshot
Overview
The Federal Office for Infrastructure, Environmental Protection and Services of the Bundeswehr is tendering a framework agreement for pharmaceutical products in 13 lots. The lots include esketamine injection, desloratadine and pivmecillinam tablets, tranexamic acid, insulin, promethazine, dexmedetomidine, glucose, ipramol inhalation solution, paracetamol suppositories, naloxone, ibuprofen tablets and brivudine tablets. Each lot title states a quantity, for example 38,565 BT for lot 1 and 12,287,200 EA for lot 12. The estimated lot term runs from 1 February 2027 to 31 January 2029. Awards use an evaluation matrix (40) and price (60). Bids are due on 23 November 2026 at 08:00 Central European Time.
Information based on the public notice
Ask about this tender
What the buyer needs
A framework agreement for 13 pharmaceutical product lots for the Bundeswehr, mainly medicines and medical supplies such as injection solutions, tablets, suppositories and inhalation ampoules. Each lot has its own quantity, and the lot quantities are stated in the lot titles with their packaging units. The notice gives the product list but not the delivery locations, which are in Annex 1 of the framework agreement.
- Bidders provide a self-declaration that no exclusion grounds apply under sections 123 and 124 GWB (procurement document VM131_12_B-V034).
- A bidder may submit tenders for up to 13 lots and may be awarded up to 13 lots.
- Bids must be submitted electronically on evergabe-online.de in German. Electronic catalogues are not allowed, and each bidder may submit one tender only.
- The buyer may ask bidders to supplement missing company documents under section 56(2) VgV.
Lots
LOT-0001 ·Los 1 - 38.565 BT ESKETAMIN 25MG/ML INJ.-LSG. DSFL. 10ML
LOT-0002 ·Los 2 - 4.000 EA DESLORATADIN 5MG TABLETTE
LOT-0003 ·Los 3 - 8.640 EA PIVMECILLINAM TABLETTEN
LOT-0004 ·Los 4 - 33.770 AM TRANEXAMSAEURE INJE
LOT-0005 ·Los 5 - 2.165 BT INSULIN INJEKTION
LOT-0006 ·Los 6 - 480 BT PROMETHAZIN 20MG/ML TRPF
LOT-0007 ·Los 7 - 3.360 BT DEXMEDETOMIDIN 1MG/10ML INJ
LOT-0008 ·Los 8 - 40.980 AM GLUCOSTERIL INJ 40% 10ML /20
LOT-0009 ·Los 9 - 5.780 AM IPRAMOL TEVA 0,5+2,5MG/2,5ML INH.AMP /20
LOT-0010 ·Los 10 - 1.200 EA PARACETAMOL 250MG SUPPOSITORIEN
LOT-0011 ·Los 11 - 36.650 AM NALOXONHYDROCHLORID INJEKTION
LOT-0012 ·Los 12 - 12.287.200 EA IBUPROFEN TABLETTEN 400MG
LOT-0013 ·Los 13 - 64.148 EA BRIVUDIN 125MG TABLETTE
Tender details
- Buyer
- Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der Bundeswehr
- Country
Germany
- Procedure
- Open procedure, flagged as accelerated, framework agreement partly with and partly without reopening of competition
- Classification
- Pharmaceuticals and laboratory supplies · CPV 33600000
- Notice reference
- 747795-2026
- Subject
- Pharmaceutical products, 13 lots (CPV 33600000)
- Deadline for receipt of tenders
- 23 November 2026 at 08:00 CET (UTC+01:00), 07:00 UTC
- Opening of tenders
- 23 November 2026 at 08:00 CET (UTC+01:00)
- Estimated lot term
- 1 February 2027 to 31 January 2029
- Award criteria
- Evaluation matrix, weight 40; price, weight 60
- Tender validity
- 5 months
- Review body
- Bundeskartellamt, Vergabekammer des Bundes
What to check in the tender documents
- The notice gives no estimated value for the framework agreement or for any lot.
- The procurement documents on evergabe-online.de were not read, so the performance specification, delivery locations (Annex 1), price sheets and the evaluation matrix are not reviewed here.
- The change notice gives no change description (the field shows a dash), so what changed from the earlier notice is not stated.
- The notice gives no award date and no estimated date of award.
Original notice
Read the original description
1/DLII6/VM131 - RV div. Arzneimittel
Official source: TED notice 747795-2026 (HTML view, change notice) and canonical snapshot ↗
https://ted.europa.eu/en/notice/-/detail/747795-2026
Source retrieved: 2026-11-11T18:43:21Z